TP53 and endometrial cancer: As suggested by Vermij et al., pathologists should receive specialized training for p53 IHC evaluation in patients with endometrial cancer (training tutorial available at http://www.gpec.ubc.ca/p53 (accessed on 28 March 2023)) [13].